サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363285

構造的心疾患用デバイスの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2023年～2030年

Structural Heart Devices Market Size, Share & Trends Analysis Report By Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Mitral Repair, Left Atrial Appendage Closure), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 90 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
構造的心疾患用デバイスの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月26日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

構造的心疾患用デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の構造的心疾患用デバイス市場規模は2023年から2030年にかけてCAGR 9.3％を記録し、2030年には128億米ドルに達すると予測されています。

この市場は、心血管疾患の急増とヘルスケア支出の増加により、今後8年間で急激な成長が見込まれています。

欠損症は出生時に発症することがほとんどであり、そのため国の5歳未満死亡率に直接影響します。そのため、治療へのアクセスを向上させるために、世界中のさまざまな政府機関によって厳格な措置が取られています。疾病管理予防センターは、心臓疾患の効率的な管理のための公共行動計画を策定しています。

さらに、他の組織も構造的心疾患治療のシナリオ改善に取り組んでいます。例えば、2016年11月、心臓血管研究財団（CRF）は、構造的心疾患の診断と治療に焦点を当てた学術誌の創刊を発表しました。タイトルは『Structural Heart』：The Journal of the Heart Teamと題され、2017年5月に創刊される予定です。これにより、この分野に投資される資本とともに研究開発活動が活発化し、技術的進歩がもたらされることが期待されます。

構造的心疾患用デバイス市場レポートハイライト

  • 外科的大動脈弁置換術（SAVR）が2022年の市場を独占し、経カテーテル的大動脈弁置換術（TAVR）が僅差で続いた。大動脈弁置換術が大動脈弁狭窄症の治療法として長く使われているためと考えられます。
  • 左心房付属器閉鎖術（LAAC）は、その低侵襲性から最も急成長している手技のひとつと予想されます。また、脳卒中のリスク軽減にも役立つため、より高い需要が見込まれます。
  • 地域別では、北米が2016年に最大の構造的心疾患用デバイス市場シェアを占めており、予測期間中もその地位を維持すると予測されています。認知性心疾患の有病率の高さが、この優位性の主な理由です。さらに、2014年9月に米国疾病予防管理センター（CDC）と米国小児科学会（AAP）によって課された新生児に対するCCHDスクリーニングの義務化も、この地域の成長に寄与しています。
  • アジア太平洋地域も予測期間中に急成長が見込まれます。この地域における治療へのアクセスと能力の向上が、この成長の主な理由です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 構造的心疾患用デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 構造的心疾患用デバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 構造的心疾患用デバイス市場：タイプ別推定・動向分析

  • 構造的心疾患用デバイス市場：重要なポイント
  • 構造的心疾患用デバイス市場：タイプの動向と市場シェア分析、2022年および2030年
  • SAVR（外科的大動脈弁置換術）
  • TAVR（経カテーテル大動脈弁置換術）
  • 僧帽弁形成術（弁輪形成術）
  • LAAC（左心耳閉鎖術）

第5章 構造的心疾患用デバイス市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別の構造的心疾患用デバイス市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Medtronic plc
    • St. Jude Medical, Inc.
    • Boston Scientific Corporation
    • CardioKinetix
    • Comed B.V.
    • Edwards Lifesciences Corporation
    • LivaNova PLC
    • Abbott Laboratories
    • JenaValve Technology, Inc.
    • Biomerics, LLC
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America structural heart devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 6 Europe structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe structural heart devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 UK structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 10 France structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 11 Italy structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 Spain structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 13 Sweden structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Norway structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 15 Denmark structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific structural heart devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 19 Japan structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 20 India structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 21 Australia structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 Thailand structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 23 South Korea structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 24 Latin America structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 Latin America structural heart devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa structural heart devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE structural heart devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait structural heart devices market, by type, 2018 - 2030 (USD Million)  

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Structural heart devices: Market outlook
  • Fig. 9 Structural heart devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Structural heart devices market driver impact
  • Fig. 15 Structural heart devices market restraint impact
  • Fig. 16 Structural heart devices market strategic initiatives analysis
  • Fig. 17 Structural heart devices market: Type movement analysis
  • Fig. 18 Structural heart devices market: Type outlook and key takeaways
  • Fig. 19 SAVR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 TAVR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Mitral repair market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 LAAC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global structural heart devices market: Regional movement analysis
  • Fig. 24 Global structural heart devices market: Regional outlook and key takeaways
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-785-8

Structural Heart Devices Market Growth & Trends:

The global structural heart devices market size is expected to reach USD 12.8 billion by 2030, registering a CAGR of 9.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is expected to witness exponential growth over the next 8 years due to the rapid increase in cardiovascular conditions and increasing power of healthcare expenditure.

The defects are mostly present at birth, thereby directly affecting the under-5 mortality rate of a country. Therefore, rigorous actions are being undertaken by various government bodies across the globe to increase access to treatment. The Centers for Disease Control and Prevention have a public action plan for efficient management of cardiac conditions.

In addition, other organizations are working on improving the scenario for structural heart disease treatment. For instance, in November 2016, the Cardiovascular Research Foundation (CRF) announced a launch of a journal focusing on the diagnosis and treatment of structural heart defects. It was titled Structural Heart: The Journal of the Heart Team and is expected to be launched in May 2017. This is expected to trigger research & development activities along with capital invested in this field, resulting in technological advancements.

Structural Heart Devices Market Report Highlights:

  • Surgical Aortic Valve Replacement (SAVR) dominated the market in 2022, closely followed by Transcatheter Aortic Valve Replacement (TAVR). It can be attributed to the longest presence of the technique in the treatment regimen of aortic stenosis
  • Left Atrial Appendage Closure (LAAC) is anticipated to be one of the fastest-growing segment owing to the minimally invasive nature of the procedure. It also helps in the reduction of risk of stroke, thus is projected to have a higher demand
  • Geographically, North America held the largest structural heart devices market share in 2016 and is expected to maintain its position during the forecast period. A high prevalence of cognitive heart diseases is the key reason for this dominance. Moreover, the mandatory CCHD screening for newborns imposed by the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) in September 2014 also contributes to the growth in this region
  • Asia Pacific is also expected to witness rapid growth over the forecast period. The improved access and capability for treatments in this region is the key reason for this growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Structural Heart Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Structural Heart Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Structural Heart Devices Market: Type Estimates & Trend Analysis

  • 4.1. Structural Heart Devices Market: Key Takeaways
  • 4.2. Structural Heart Devices Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. SAVR (Surgical Aortic Valve Replacement)
    • 4.3.1. SAVR (Surgical Aortic Valve Replacement) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. TAVR (Transcatheter Aortic Valve Replacement)
    • 4.4.1. TAVR (Transcatheter Aortic Valve Replacement) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Mitral Repair (Annuloplasty)
    • 4.5.1. Mitral repair (annuloplasty) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. LAAC (Left Atrial Appendage Closure)
    • 4.6.1. LAAC (Left Atrial Appendage Closure) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Structural Heart Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Structural Heart Devices Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Medtronic plc
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. St. Jude Medical, Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. CardioKinetix
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Comed B.V.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Edwards Lifesciences Corporation
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. LivaNova PLC
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Abbott Laboratories
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. JenaValve Technology, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Biomerics, LLC
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives